Pro-Dex Past Earnings Performance

Past criteria checks 1/6

Pro-Dex has been growing earnings at an average annual rate of 5.9%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 12.6% per year. Pro-Dex's return on equity is 9.5%, and it has net margins of 6.2%.

Key information

5.9%

Earnings growth rate

9.2%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate12.6%
Return on equity9.5%
Net Margin6.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Pro-Dex makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:PDXN Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2348352
30 Sep 2347552
30 Jun 2346752
31 Mar 2348752
31 Dec 2244752
30 Sep 2243562
30 Jun 2242562
31 Mar 2239353
31 Dec 2141563
30 Sep 2139664
30 Jun 2138654
31 Mar 2140853
31 Dec 2036753
30 Sep 2036642
30 Jun 2035642
31 Mar 2031432
31 Dec 1929432
30 Sep 1927432
30 Jun 1927432
31 Mar 1926332
31 Dec 1825332
30 Sep 1824232
30 Jun 1822232
31 Mar 1822232
31 Dec 1723232
30 Sep 1722531
30 Jun 1722531
31 Mar 1721431
31 Dec 1620431
30 Sep 1620231
30 Jun 1619131
31 Mar 1618131
31 Dec 1517031
30 Sep 1515032
30 Jun 1513032
31 Mar 1513032
31 Dec 1411-122
30 Sep 1411-121
30 Jun 1411-121
31 Mar 1410-132
31 Dec 1311-232
30 Sep 1311-232
30 Jun 1312-242

Quality Earnings: PDXN has a large one-off loss of $1.9M impacting its last 12 months of financial results to 31st December, 2023.

Growing Profit Margin: PDXN's current net profit margins (6.2%) are lower than last year (14.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PDXN's earnings have grown by 5.9% per year over the past 5 years.

Accelerating Growth: PDXN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: PDXN had negative earnings growth (-54.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (-9.8%).


Return on Equity

High ROE: PDXN's Return on Equity (9.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.